Biomarkers for Prostate Cancer
The present invention relates to compositions and methods for the detecting, treating, and empirically investigating the prostate. In particular, the present invention provides compositions and methods for using neuroligin biomarkers (e.g., NLGN-4Y) in the diagnosis, treatment, and empirical investigation of prostate disorders (e.g., prostate cancer, benign prostatic hypertrophy).
THAXTON COLBY SHAD [US]; SMITH NORM D [US]; PAZONA JOSEPH [US]; OKOTIE ONISURU T [US]
Type of Offer:
« More Biotech Patents